Posts

New venture selects Cargill’s Tennessee site to produce Calysta FeedKind® Protein

Site will house one of the largest gas fermentation facilities to produce sustainable fish feed ingredient

Minneapolis and Menlo Park, Calif. – (Nov. 29, 2016) – Cargill, Incorporated and Calysta, Inc., along with several third-party institutions, plan to invest in the creation of the world’s largest gas fermentation facility in Memphis, Tenn. to produce Calysta’s FeedKind® protein, a family of sustainable, traceable nutritional ingredients for fish, livestock and pets.

The new venture plans to build and operate this facility on Cargill’s 69-acre property on President’s Island, where Cargill currently produces corn oil and stores and distributes sweetener products. The facility is expected to come online in late 2018, producing up to 20,000 metric tons per year of FeedKind® protein initially and expanding up to 200,000 metric tons per year when operating at full capacity.

Upon completion of the plant, the new venture expects to hire 75 permanent employees and expand to 160 people when the plant is at full ramp-up.

“Cargill has been a part of the Memphis community for 40 years. With the strong support of the state of Tennessee, Shelby County and City of Memphis, we are pleased that the venture chose to locate the facility in Memphis,” said Cargill’s Global Vice President of Bioindustrial, Brian Silvey. “The venture’s building of a state-of-the-art fermentation facility on the existing Cargill Memphis site reaffirms our commitment to the community and state and our pledge to strategically invest in aquaculture as an ever increasingly important source of protein.”

FeedKind® protein is a proprietary, competitively priced, new feed ingredient initially targeted as an alternative to fishmeal for the aquaculture industry. It is produced using the world’s only commercially validated gas fermentation process. Cargill and Calysta jointly will be marketing FeedKind® protein globally.

“With a proven and proprietary fermentation platform, Calysta is introducing a scalable and disruptive protein source critical to meeting the needs of a growing global population. Partnering with Cargill, a leader in fermentation and protein production, and others to invest in the establishment of the venture as the first U.S. manufacturing plant to commercially produce FeedKind® protein, significantly accelerates FeedKind® protein’s launch in the aquaculture industry at commercial scale. This venture is an important first step to deploying this technology globally,” said Calysta President and Chief Executive Officer, Alan Shaw, Ph.D.

In September 2016, Calysta opened an R&D and market introduction facility in the United Kingdom to produce samples of FeedKind® protein that can be used in aquaculture, livestock and pet markets worldwide.

Cargill employs approximately 274 employees in its corn, cotton, metals, grain, and farmer service businesses across its 14 locations in Tennessee.

###

About Cargill
Cargill provides food, agriculture, financial and industrial products and services to the world. Together with farmers, customers, governments and communities, we help people thrive by applying our insights and 150 years of experience. We have 150,000 employees in 70 countries who are committed to feeding the world in a responsible way, reducing environmental impact and improving the communities where we live and work.

About Calysta
Calysta, Menlo Park, CA, is an innovator in sustainable products to improve worldwide food security. Calysta Nutrition develops and commercializes FeedKind® protein, a sustainable, traceable alternative feed ingredient for fish, livestock and pet nutritional products

Contacts
Cargill: Kelly Sheehan, Kelly_Sheehan@Cargill.com, 952.742.4204
Calysta: Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, ext 200, or Calysta Media Information, info@calystaenergy.com; Steven Flanagan, sflanagan@webershandwick.com, +44 (0)7557 210989

Calysta Names Tomas Belloso As Vice President, Regulatory Affairs

Menlo Park, CA – November 7, 2016 – Calysta, Inc. (www.calysta.com) today named Tomas Belloso, Ph.D., to the new position of Vice President, Regulatory Affairs.  He reports to Josh Silverman, Ph.D., Chief Product and Innovation Officer, and is responsible for the company’s regulatory and quality management programs and strategy.

“Tomas Belloso brings Calysta over a decade of senior regulatory, quality and product management experience in the feed and animal health industries,” Dr. Silverman said.  “He is an important addition to our management team as Calysta moves toward commercial production of FeedKind® protein.   FeedKind protein is a proprietary, competitively priced new fish and animal feed ingredient targeted at replacing fishmeal.”

Dr. Belloso previously served as Regulatory Compliance Manager at the Feed Division of Wilbur-Ellis, a $3 billion international marketer and distributor of agricultural products, animal feed and specialty chemicals and ingredients.  Prior to that, he held senior regulatory and product management positions at Royal Canin USA, a subsidiary of MARS, Inc., Nestle Purina, Monsanto and Elanco Animal Health.

He holds a Ph.D. in animal sciences and a Master’s degree in dairy sciences from the University of Florida, and a Bachelor’s degree in animal sciences from Universidad Rafael Urdaneta in Venezuela.

About Calysta
Calysta, Menlo Park, CA, is an innovator in sustainable products to improve worldwide food security. Calysta Nutrition develops and commercializes FeedKind® protein, a sustainable, traceable alternative feed ingredient for fish, livestock and pet nutritional products.

For more information contact Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, x.200; Natalie Buxton, nbuxton@WeberShandwick.com, 0141 333 0557 or Calysta Media Information, info@calystaenergy.com.

Calysta wins global award for protein innovation

Menlo Park, CA – September 23, 2016 – Calysta’s FeedKind® protein, a new fish and animal feed ingredient, has been named as the Most Disruptive Innovation at the Bridge2Food Protein Awards.

The award, presented at the 9th Protein Summit in Lille, France, comes just days after Calysta officially opened its market introduction facility to produce FeedKind in Teesside, England.

Dr. Alan Shaw, Calysta President and CEO, said: “We’re extremely pleased to have achieved this global accolade that recognises our proprietary technology as a game-changing innovation.

“With FeedKind, Calysta has an exciting opportunity to offer traceable and safe protein that will sustainably help feed the world for decades to come.”

Calysta has partnered with Cargill for production of FeedKind protein in North America and entered into a global joint marketing agreement. A global production facility is expected to open in the United States within two years.

Member of the judging panel, Dr. Anne Wagner, Corporate Research & Development Director at Tereos, said:  “We felt that we needed to award an innovation which is truly disruptive both from a technological point of view and also one that identifies alternative sources of protein to meet the protein demands of a growing population”.

Located in the Netherlands, Bridge2Food is a research group that supports international organisations and businesses in the food and animal feed industries in relation to protein ingredients.

Ends                                                                                                                                                                          23 September 2016

For more information contact: Mhairi Greer, mgreer@webershandwick.com / 07976 443626 or Lyn Christenson, lyn@linkagesgroup.com / 650.492.6880 / Calysta Media Information, info@calystaenergy.com.

About Calysta
Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable products. Calysta Nutrition develops and commercialises fish and livestock nutritional products improving food security worldwide.

UK Opening Marks First Step In Global Scale-Up For Novel Aquaculture Protein

Calysta to produce FeedKind® protein, a sustainable feed ingredient, in Teesside

Wilton, United Kingdom – September 19, 2016 – Leading retailers, producers, investors and government representatives from around the globe gathered in the north of England today to mark the opening of an historic facility that will help meet the protein demands of the world’s growing population.

USA-based Calysta (www.calysta.com) chose Teesside as the base for its state-of-the-art facility to manufacture sample quantities of FeedKind® protein, a proprietary, competitively priced new fish and animal feed ingredient targeted at replacing fishmeal.

Produced using the world’s only commercially validated gas fermentation process, FeedKind protein is a natural, traceable and safe non-animal source of protein. FeedKind protein is approved for sale and use in many animal feeds in the EU and has been tested on multiple fish species, including salmon. The facility will become fully operational in Q4 2016.

Earlier this year Calysta partnered with Cargill for production of FeedKind protein in North America and entered into a global joint marketing agreement.  A world scale plant is expected to open in the United States by 2018.

Alan Shaw, Ph.D, Calysta President and CEO, said: “The opening of this plant represents the end of a decade of development and heralds a new era in the race to sustainably feed the world’s growing population.

“By 2050 the global population is expected to rise from 7.4 billion today to 9.6 billion and require 70 per cent more protein than is currently available. Calysta can help meet this need by supplying the aquaculture industry with a naturally produced, sustainable and traceable feed alternative to replace conventional ingredients based on fishmeal and soya.  Calysta’s proprietary technology enables retailers and consumers to have increased confidence in the integrity of their food.

“Our first focus is the salmon farming industry and we were very pleased to welcome representatives from a number of key producers today. FeedKind protein has been shown to improve growth rates, nitrogen retention and gut health in Atlantic salmon.”

Anna Turley, Member of Parliament for Redcar, officially opened the facility adjacent to the Centre for Process Innovation (CPI).  She was joined by Dr. Shaw and Nigel Perry, CEO of CPI.

The plant is supported by a conditional Exceptional Regional Growth Fund (EGRF) award and represents a total potential investment of £30 million. When completed, the facility is expected to provide employment for 35 to 40 people.

Anna Turley MP said: “It was an honour to open Calysta’s market introduction facility today. As well as generating investment and employment in Teesside, this facility puts the UK at the forefront of the race to address the world’s growing protein demand with novel technologies. I am really pleased that Calysta have chosen to base their biotech project here and look forward to seeing the facility develop further.”

The official opening at the Wilton Centre was followed by a conference hosted by Calysta to discuss the increasing worldwide demand for fish protein, traceability and sustainability. Representatives from Marine Harvest, Sainsbury’s and Rabobank took part in a panel discussion at the event.

Based in Menlo Park, California and established in 2011, Calysta brings together experts in biotechnology and product innovation to focus on commercialising disruptive, sustainable technologies

In February 2016 Calysta announced $30 million in Series C funding including an investment from Cargill. To date, the company has raised approximately $50M.

Ends

For more information contact: Natalie Buxton, nbuxton@WeberShandwick.com, 0141 333 0557, or Lyn Christenson, lyn@linkagesgroup.com 650.492.6880, x.200 or Calysta Media Information, info@calystaenergy.com.

About Calysta
Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable products. Calysta Nutrition develops and commercialises fish and livestock nutritional products improving food security worldwide.

About the Government’s Regional Growth Fund
The Regional Growth Fund (RGF) has supported eligible projects and programmes raising private sector investment to create economic growth and lasting employment. Since its launch in 2010 it has invested £2.6 billion to help local businesses grow and take on more staff across England.

On average for every £1 invested through the RGF, the private sector has put in £5.50 with the total investment of private sector support expected to be £16 billion. 187,000 jobs have already been created and a total of 557,000 are expected by the mid-2020s.

Calysta Names Goldman Sachs Veteran Wenger As CFO & CSO

Menlo Park, CA – June 1, 2016 – Calysta, Inc. (www.calysta.com) today named Lynsey Wenger as Chief Financial Officer and Chief Sustainability Officer.  She joins Calysta following a 16-year career with The Goldman Sachs Group, where she spent the greater part of the last decade specializing in global natural resources investment banking.  Ms. Wenger will report to Alan Shaw, Ph.D., President and Chief Executive Officer. She will have responsibility for the company’s financial strategy, planning and management, and for expansion and implementation of Calysta’s long term sustainability strategy and programs.

“Lynsey Wenger brings Calysta a unique combination of skills and experience which will be essential as we enter product commercialization of FeedKind™ protein,” Dr. Shaw said.  “Her significant expertise in management of complex financial transactions at one of the world’s leading investment banks, combined with her role as a respected strategic advisor to senior management and her knowledge of global natural resources, will be valuable assets as we continue our rapid growth. We are very pleased to welcome her to our team.”

During Ms. Wenger’s career at Goldman Sachs, she managed and led investment banking activities in global natural resources ranging from international mergers and acquisitions and IPOs to multimillion-dollar equity transactions and debt placements.  Her industry experience includes natural gas and electric utilities, power, renewables and alternative energy.  Most recently, Ms. Wenger served as a Vice President in the Investment Banking Division, with responsibility for transactions in the corporate power and utility sectors.  Previously, she served in the Americas Financing Group as Head of Investment Grade Power, Utility and Midstream Debt Capital Markets. Earlier in her career she held positions in Equity Derivative Sales in the United States and Australia.

Ms. Wenger holds an MBA from The Wharton School at the University of Pennsylvania and a Bachelor of Arts degree from Duke University.

Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products. Calysta has two business units. Calysta Nutrition develops and commercializes FeedKind™ protein, a new fish and animal feed ingredient that can reduce the aquaculture and agriculture industries’ reliance on unsustainable ingredients and production methods. Calysta Materials and Energy is developing high value materials for use in industrial and consumer products with cost and performance advantages over current processes.

Contact: Mhairi Greer, mgreer@webershandwick.com, 011 44 1224 806 608, or Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, ext 200, or Calysta Media Information, info@calystaenergy.com.

Scientists to use microbes and methane to create sustainable Omega 3

Scientists are trying to find a new way to produce the nutritional fatty acids called Omega 3 that are currently sourced from fish oil from the world’s declining natural fish stocks.

In a groundbreaking branch of new science – synthetic biology –­ the team at The University of Nottingham’s Synthetic Biology Research Centre are working with biotechnology company CHAIN Biotech and industry partner Calysta, Inc. to develop microbial technology that uses microorganisms to ferment methane gas into valuable nutritional supplements.

The pioneering project is called PUFA (polyunsaturated fatty acids). It will run for a year and is being funded by industrial biotechnology catalyst grants from InnovateUK and the BBSRC with potential further significant scaling up investment from Calysta, a sustainable nutrition company based in the US.

Omega 3 fatty acids are essential for the growth, development and healthy maintenance of the brain and are incorporated in many kinds of foods and infant nutrition products as well as animal feed and health products. Currently Omega 3 fatty acids are sourced from fish oils, but wild fish stocks are under pressure and there is an urgency to find alternative sources that are both sustainable and economical.

Leading the research at Nottingham’s Synthetic Biology Research Centre, Professor Nigel Minton said: “We specialise in the use of fermentation of certain gases to produce sustainable industrial chemicals and biofuels and now, through this project, to produce vital feedstock ingredients like Omega 3 fatty acids. We will be engineering the Methanococcus microbe to produce polyunsaturated fatty acids from a cheap and replenishable feedstock – methane gas.

“There are huge potential benefits in terms of reducing dependency on fishing and also creating a new use for a plentiful gas that has a harmful effect on the environment if unharnessed. Methane is a low cost and sustainable feedstock that can be produced from a variety of renewable sources, including anaerobic digestion which is now prevalent in the UK and EU.”

Dr Basil Omar, Chief Commercial Officer at CHAIN Biotech Ltd said: “This is a great example of how publicly funded early stage research is being leveraged and commercially exploited with an industry partner to scale up successful discoveries made in the lab. This highly innovative project will draw upon CHAIN’s world leading expertise in Synthetic Biology to improve production characteristics by targeting both cell growth and product yield simultaneously with a focus on Omega 3 fatty acids. We hope it will offer a cheaper route to a high demand product with positive environmental and social knock on effects.”

Calysta, the project’s commercial partner, specialise in the production of microbial proteins for the commercial fish feed and livestock markets. Microbial proteins are already used to make foods like the popular savoury spreads made from yeast extract. Fish farming is growing in response to increased global demand for seafood and Calysta has developed and is commercialising a new patented product called FeedKind™ protein to provide a sustainable fish food ingredient for the fish farming industry. The company will offer a fast track to scaling up of the PUFA manufacturing process. Calysta is based in California and will open a market introduction facility for FeedKind in Teesside, England, later this year. A commercial-scale plant in the US is expected to come online in 2018.

Alan Shaw, Ph.D., Calysta President and Chief Executive Officer, said:”Partnering the University of Nottingham and CHAIN Biotech in this project means we can develop the next generation of FeedKind protein.

“FeedKind protein is a natural, safe, high-quality, non-GMO protein source produced by a single cell organism, using a natural, proprietary fermentation process. By replacing fishmeal, fish oil and soy protein concentrate with a nutritious naturally occurring protein, the aquaculture industry can reduce its impact on the environment and on wild fisheries while continuing to grow to feed the world’s population.

“Successful completion of this research will result in a step-change in sustainable human nutrition and will be welcomed by the food industry, retailers and consumers globally.”

—Ends—

 

More information is available from Professor Nigel Minton, Director BBSRC/EPSRC Synthetic Biology Research Centre, University of Nottingham on +44 (0)115 846 7458, nigel.minton@nottingham.ac.uk ; or Dr Basil Omar Chief Commercial Officer CHAIN Biotechnology Ltd on +44 (0)7771 660 800 basil.omar@chainbiotech.com

or Emma Rayner in the Communications Office at The University of Nottingham, on +44 (0)115 951 5793, emma.rayner@nottingham.ac.uk. For information on Calysta contact Natalie Buxton at Weber Shandwick on +44 (0)141 333 0557 or nbuxton@webershandwick.com

Our academics can now be interviewed for broadcast via our Media Hub, which offers a Globelynx fixed camera and ISDN line facilities at University Park campus. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email mediahub@nottingham.ac.uk or see the Globelynx website for how to register for this service.

For up to the minute media alerts, follow us on Twitter

Notes to editors: The University of Nottingham has 43,000 students and is ‘the nearest Britain has to a truly global university, with a “distinct” approach to internationalisation, which rests on those full-scale campuses in China and Malaysia, as well as a large presence in its home city.’ (Times Good University Guide 2016). It is also one of the most popular universities in the UK among graduate employers and the winner of ‘Outstanding Support for Early Career Researchers’ at the Times Higher Education Awards 2015. It is ranked in the world’s top 75 by the QS World University Rankings 2015/16, and 8th in the UK by research power according to the Research Excellence Framework 2014. It has been voted the world’s greenest campus for three years running, according to Greenmetrics Ranking of World Universities.

Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…

About Calysta

Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products. Calysta has two business units. Calysta Nutrition develops and commercializes FeedKind™ protein, a new fish and animal feed ingredient that can reduce the aquaculture and agriculture industries’ reliance on unsustainable ingredients and production methods. Calysta Materials and Energy is developing high value materials for use in industrial and consumer products with cost and performance advantages over current processes.

Carbon Trust Reports Calysta FeedKind™ Protein Is Proven Sustainable Alternative To Conventional Fish Feeds

CALYSTA

1140 O’Brien Drive
Menlo Park, CA 94025
650-492-6880
www.calysta.com

For Immediate Release

Menlo Park, CA – (April 12, 2016) – Calysta, Inc. (www.calysta.com) announced that leading sustainability advisors The Carbon Trust (www.carbontrust.com), in a report released today, has assessed Calysta’s FeedKind™ protein against a number of key sustainability metrics, finding that it nearly eliminates the need for two increasingly scarce resources –  water and agricultural land – for production of fish feed for the aquaculture industry.   In addition, FeedKind protein does not rely on use of wild caught fish, reducing pressure on global fish stocks. FeedKind protein is a natural, safe, non-GMO sustainable fish feed ingredient.  It is currently approved for sale in the European Union.

The report provides a detailed analysis of FeedKind protein taking into account a variety of environmental sustainability criteria, and concludes that FeedKind protein offers significant advantages over current fish feed ingredients.  FeedKind protein was shown to use 77-98% less water than alternative ingredients including soy and wheat proteins.  It also requires almost no agricultural land to produce, freeing that land for other food crops.  In fact, one commercial scale FeedKind protein plant, if used to replace soy products for fish feed, would free up enough land to feed as many as 250,000 people.  The land area represented is equal to an area the size of Chicago, Illinois or Birmingham, England or Seoul, Korea.

Further, as FeedKind production moves toward greater use of renewable biogas and electric power, the report concludes FeedKind protein will have “a carbon footprint comparable to or better than many other feed sources.”

“FeedKind protein provides a new path to sustainability for the aquaculture industry,” said Alan Shaw, Ph.D., Calysta President and CEO.  ”The global population is expected to reach nine billion by 2050, requiring up to 70% more food.  Fish, as an important source of protein, will play a major role in ensuring food security.  Food production to meet this need must be sustainable, and lower water use and land use are keys to reaching that goal. Today’s report shows that FeedKind protein meets that test.”

Tom Cumberlege, a senior consultant at The Carbon Trust and one of the report’s authors, added, “Aquaculture is growing at an astonishing rate and has now overtaken beef production. But it is essential that the industry manages its growth sustainably by finding innovations to reduce environmental impacts. Agricultural land and fresh water are becoming increasingly valuable resources as the climate changes and we need to find ways to feed a growing population. FeedKind protein meets these requirements by requiring minimal land and water resources with the added potential of a low carbon footprint when using renewable sources of energy and biogas.”

In January, Calysta announced it will open an R&D and market introduction facility in the United Kingdom for further development of the commercial production process for FeedKind protein.  The facility is expected to open in early 2017.  In February, Calysta announced $30 million in Series C funding with Cargill, the Municipal Employee Retirement System (MERS) of Michigan and Old Westbury Global Real Assets Fund LLC.  Also participating were current Calysta investors Walden Riverwood Ventures, Aqua-Spark and Pangaea Ventures.  In addition to the funding, Calysta and Cargill will collaborate in the North American manufacturing and global marketing of FeedKind protein.

For a copy of today’s report, click here.

About Calysta
Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products. Calysta has two business units. Calysta Nutrition develops and commercializes FeedKind™ protein, a new fish and animal feed ingredient that can reduce the aquaculture and agriculture industries’ reliance on unsustainable ingredients and production methods. Calysta Materials and Energy is developing high value materials for use in industrial and consumer products with cost and performance advantages over current processes.

About The Carbon Trust
The Carbon Trust is an independent company with a mission to accelerate the move to a sustainable, low-carbon economy. The Carbon Trust:

  • advises businesses, governments and the public sector on opportunities in a sustainable, low-carbon world;
  • measures and certifies the environmental footprint of organisations, products and services;
  • helps develop and deploy low-carbon technologies and solutions, from energy efficiency to renewable power.

Contacts
Calysta: Natalie Buxton, nbuxton@WeberShandwick.com; 0141 333 0557; Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, ext 200, or Calysta Media Information, info@calystaenergy.com

Carbon Trust: Carbon Trust press office, 020 7170 7050 or press@carbontrust.com.

 

Calysta Names Sheldon Vice President, Operations

CALYSTA

1140 O’Brien Drive
Menlo Park, CA 94025
650-492-6880
www.calysta.com

For Immediate Release

Menlo Park, CA – February 16, 2016 – Calysta, Inc. (www.calysta.com) today named Douglas Sheldon to the new position of Vice President, Operations.  He will report to Alan Shaw, Ph.D., President and Chief Executive Officer.  Mr. Sheldon will have responsibility for the overall operations of the company, including the construction and operation of production facilities, oversight of capital projects and expansions, supply chain, development of world class production capabilities and long term manufacturing strategy that addresses future capacity additions in line with the broader strategy of the company and its current and future business partners.

“Doug Sheldon brings Calysta 30 years operations management experience from Dow Chemical, one of the world’s leading chemical manufacturers,” Dr. Shaw said.  “He has supervised construction and operation of complex facilities in the U.S., Europe and Asia, and has worked extensively with Dow commercial partners.  His global expertise will be vital as Calysta focuses on accelerated commercialization of FeedKind™ protein, our sustainable fishmeal ingredient alternative for the aquaculture industry.”

During three decades at Dow, Mr. Sheldon held positions ranging from engineering, capital projects, plant operations and management of world scale assets to development of Dow’s global site services for facilities in the Americas, Europe and Central and Southeast Asia.  Most recently, he oversaw site expansions, divestitures, consolidations and site service development for multiple Dow global facilities as Global Offering Director and Commercial Director for the Dow Services Business, and for the Mergers, Acquisitions and Divestitures Technology Center for Dow operations in Houston, Texas.  

Previously, as Program Director, Thailand Growth Project, he contributed to Dow’s presence in Thailand and led the >$2 billion Thailand MEGA project, starting with the due diligence of Dow’s JV partner’s Cracker and resulting in several downstream derivative Dow facilities. He also held management positions at Dow plants in the Netherlands and in Texas, Illinois, Missouri and Georgia.  Mr. Sheldon holds a Bachelor’s degree in chemical engineering from the University of Michigan.

Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products. Calysta has two business units. Calysta Nutrition develops and commercializes FeedKind™ protein, a new fish and animal feed ingredient that can reduce the aquaculture and agriculture industries’ reliance on unsustainable ingredients and production methods. Calysta Materials and Energy is developing high value materials for use in industrial and consumer products with cost and performance advantages over current processes. 

Contact: Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, ext 200, or Calysta Media Information, info@calystaenergy.com.

Calysta Completes $30 million Series C Financing, Accelerating the Introduction of FeedKind™ Protein at Commercial Scale

Menlo Park, CA – (February 2, 2016) ) – Calysta, Inc. today announced $30 million in Series C funding with Cargill, the Municipal Employee Retirement System (MERS) of Michigan and Old Westbury Global Real Assets Fund LLC.  Also participating were current Calysta investors Walden Riverwood Ventures, Aqua-Spark and Pangaea Ventures. Calysta intends to use the Series C investment to advance new product development, commercial manufacturing and continued advances in its proprietary state-of-the-art gas fermentation platform.

With this funding, Brian Silvey, Cargill Vice President, Corn Milling, and Edward Mikolay, MERS of Michigan Senior Investment Officer and Director of Private Markets, will be joining the Calysta Board of Directors.

In addition to the funding, Calysta and Cargill will collaborate in the North American manufacturing and global marketing of Calysta’s FeedKind™ protein, a family of high value environmentally-friendly nutritional feed additives for fish and livestock.

“This collaboration with Cargill, a world leader in fermentation and protein production, is expected to dramatically accelerate market introduction of FeedKind™ protein at commercial scale,” said Alan Shaw, Ph.D., Calysta President and CEO. “We are also very pleased to add Bessemer and MERS, investors who bring a long term view of capital deployment, to Calysta’s distinguished group of investors. Calysta is providing the aquaculture industry with a proprietary sustainable alternative to conventional fishmeal ingredients.  This in turn addresses the widely-recognized concern about a worldwide shortage of protein, a serious potential threat to global food security.”

“Calysta brings key innovations in gas fermentation that complement Cargill’s global expertise in engineering, manufacturing and marketing,” said Brian Silvey, Cargill Vice President, Corn Milling.

In January 2016 Calysta announced conditional receipt of a grant from the United Kingdom for development of a Market Introduction Facility in northern England.  The UK facility is Calysta’s first research and market introduction facility for FeedKind™ protein.

About Calysta

Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products for food and energy security. Calysta has two business units. Calysta Nutrition develops and commercializes FeedKind™ protein, a new fish and animal feed ingredient that can reduce the aquaculture and agriculture industries’ reliance on unsustainable ingredients and production methods. Calysta Energy is developing high value materials for use in industrial and consumer products with cost and performance advantages over current processes.

Contacts
Natalie Buxton, nbuxton@WeberShandwick.com; 0141 333 0557; Lyn Christenson, lyn@linkagesgroup.com, 650.492.6880, ext 200, or Calysta Media Information, info@calystaenergy.com

US biotech company, Calysta Inc. to open its first R&D and market introduction facility in the UK

CALYSTA

1140 O’Brien Drive
Menlo Park, CA 94025
650-492-6880
www.calysta.com

For Immediate Release

Located at the Centre for Process Innovation (CPI), Teesside, Calysta will develop the production process for FeedKind™ protein, a new fish feed ingredient to reduce the aquaculture industry’s use of fishmeal. FeedKind™ protein – a natural, safe, non-GMO sustainable fish feed ingredient is approved for sale in the European Union.

Calysta, Inc. (www.calysta.com) based in California, through its subsidiary Calysta (UK) Ltd., has received a conditional award of up to £2.8 million Exceptional Regional Growth Fund (eGRF) grant subject to due diligence from the UK Government. This will contribute to a £30 million first phase investment over ten years by Calysta to develop a Market Introduction Facility to undertake R&D critical to commercialise FeedKind and develop the technology for other applications.

The project is expected to both safeguard and create up to 39 positions in science, engineering and operations, along with indirect jobs benefits in construction and the supply chain.

Calysta plan to locate a novel loop reactor adjacent to CPI’s existing National Industrial Biotechnology Facility 2 (NIBF2) facility. This loop reactor will incorporate Calysta’s proprietary, best-in-class gas fermentation technology.  CPI staff at the Centre of Excellence will then gain experience in operating the facility under Calysta’s supervision.

Alan Shaw, Ph.D., Calysta President and CEO said: “The eRGF grant is a major vote of confidence for us from the UK Government. After looking at potential sites around Europe, we look forward to building Calysta’s first plant in Teesside.

“Teesside remains an important centre for the process industry,” he added. “We are keen to capitalise on the area’s commercial attractiveness, technical skills and research and development expertise. Our plant will not only provide a boost for the economy of North East England, but will also support the UK’s goal to become a world leader in the emerging industrial biotechnology sector by generating game changing technology in gas fermentation and synergistic applications.”

FeedKind™ is manufactured using a natural process similar to the production of yeast-extract sandwich spreads.  Studies have confirmed the nutritional value of the feed, based on criteria such as growth performance and animal health.

Calysta is marketing FeedKind™ Aqua to the global salmon farming industry.  For the first time, FeedKind™ Aqua provides the aquaculture industry with the opportunity to further improve its sustainability profile as it grows to meet increasing global demand for fish protein. In the UK alone, the salmon farming industry is expected to grow by 50% by 2020. By replacing fishmeal with a nutritious naturally occurring protein, the industry can reduce its impact on the environment and on wild fisheries, while offering consumers a more sustainable product.

Ends

For more information contact: Natalie Buxton, nbuxton@WeberShandwick.com, 0141 333 0557 or Calysta Media Information, info@calystaenergy.com, 650 492 6880

About Calysta
Calysta, Inc. (www.calysta.com), Menlo Park, CA, is an innovator in sustainable industrial products for food and energy security. Calysta has two business units. Calysta Nutrition develops and commercializes fish and livestock nutritional products. Calysta Energy is developing high value industrial chemical products with cost and performance advantages over current processes.

About the Regional Growth Fund
The Regional Growth Fund has supported projects and programmes raising private sector investment to create economic growth and lasting employment.  It has invested £2.7 billion to help businesses in England to grow; and is expected to create or safeguard over 557,000 jobs by the mid 2020’s.